We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ON DEFENSIVE FOR MUZZLING EXPERT IN ANTIDEPRESSANT STUDY
FDA ON DEFENSIVE FOR MUZZLING EXPERT IN ANTIDEPRESSANT STUDY
April 19, 2004
The FDA is defending its decision not to allow an agency expert to testify about possible links between the use of some antidepressant drugs and an increased risk of suicide in young people taking the medications.